Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct;39(10):1886-1891.
doi: 10.1002/mds.29839. Epub 2024 May 26.

Role of Bβ1 overexpression in the pathogenesis of SCA12

Affiliations

Role of Bβ1 overexpression in the pathogenesis of SCA12

Chengqian Zhou et al. Mov Disord. 2024 Oct.

Abstract

Background: Spinocerebellar ataxia type 12 (SCA12) is a neurodegenerative disease caused by a CAG/CTG repeat expansion at the PPP2R2B locus.

Objective: We investigated how the CAG repeat expansion within the PPP2R2B 7B7D transcript influences the expression of Bβ1 and a potential protein containing a long polyserine tract.

Methods: Transcript and protein expression were measured using quantitative PCR (qPCR) and Western blot, respectively, in an SK-N-MC cell model that overexpresses the full-length PPP2R2B 7B7D transcript. The apoptotic effect of a protein containing a long polyserine tract on SK-N-MC cells was evaluated using caspase 3/7 activity.

Results: The CAG repeat expansion increases the expression of the PPP2R2B 7B7D transcript, as well as Bβ1 protein, in an SK-N-MC cell model in which the full-length PPP2R2B 7B7D transcript is overexpressed. The CAG repeat expansion within the 7B7D transcript is translated into a long polyserine tract that triggers apoptosis in SK-N-MC cells.

Conclusions: The SCA12 mutation leads to overexpression of PPP2R2B Bβ1 and to expression of a protein containing a long polyserine tract; both these effects potentially contribute to SCA12 pathogenesis. © 2024 International Parkinson and Movement Disorder Society.

Keywords: Bβ1; polyserine; spinocerebellar ataxia type 12.

PubMed Disclaimer

Conflict of interest statement

Relevant conflict of interest/financial disclosure: Nothing to report.

References

    1. Choudhury S et al. Clinical Characterization of Genetically Diagnosed Cases of Spinocerebellar Ataxia Type 12 from India. Mov. Disord. Clin. Pract 5, 39–46 (2017). - PMC - PubMed
    1. Srivastava AK, Takkar A, Garg A & Faruq M Clinical behaviour of spinocerebellar ataxia type 12 and intermediate length abnormal CAG repeats in PPP2R2B. Brain 140, 27–36 (2017). - PubMed
    1. Cohen RL & Margolis RL Spinocerebellar ataxia type 12: clues to pathogenesis. Curr. Opin. Neurol 29, 735–742 (2016). - PubMed
    1. Holmes SE et al. Expansion of a novel CAG trinucleotide repeat in the 5’ region of PPP2R2B is associated with SCA12. Nat. Genet 23, 391–392 (1999). - PubMed
    1. O’Hearn E, Holmes SE & Margolis RL Spinocerebellar ataxia type 12. Handb. Clin. Neurol 103, 535–547 (2012). - PubMed

MeSH terms

Supplementary concepts

LinkOut - more resources